Servicio de Urología, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain.
Servicio de Urología, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain.
Actas Urol Esp (Engl Ed). 2021 Dec;45(10):609-614. doi: 10.1016/j.acuroe.2021.04.013. Epub 2021 Nov 9.
The minimally invasive surgical approach to adrenal gland pathology is the most widely used nowadays, and retroperitoneoscopy occupies a relevant place. However, the evolution of these techniques towards even less invasive surgery through single-port access is anecdotal. The aim of this work is to describe our initial experience in single-port retroperitoneoscopic surgery (SPORS) of the adrenal gland focusing on perioperative data and postoperative pain.
We collected and analyzed the demographic and operative data of a series of patients undergoing adrenalectomy through SPORS. All procedures were performed through a single 3-4 cm subcostal incision with a multichannel port. Surgical data such as operative time, bleeding, length of stay and presence of complications were collected. We used the visual analog scale (VAS) for postoperative pain assessment.
From December 2018 to August 2020, 6 patients with different types of adrenal pathology underwent consecutive surgeries in our Department by the same surgeon using SPORS. All surgeries were performed without requiring accessory trocar placement or reconversion to open surgery. The mean operative time was 91.6 ± 16.3 min, with <150 mL bleeding, mean length of stay of 35.8 ± 13.3 h and postoperative pain of VAS ≤3 (median 0.5). The mean size of specimens was 57.8 ± 18 mm. No complications were reported according to the Clavien-Dindo scale.
Even in initially adverse cases, SPORS adrenalectomy is a feasible and safe technique with good cosmetic and perioperative results.
现今,微创外科方法被广泛应用于治疗肾上腺疾病,其中后腹腔镜手术占据了重要地位。然而,这些技术朝着单孔入路的微创方向发展仍处于探索阶段。本研究旨在介绍我们在单孔后腹腔镜肾上腺手术(SPORS)方面的初步经验,重点关注围手术期数据和术后疼痛。
我们收集并分析了一系列接受 SPORS 肾上腺切除术患者的人口统计学和手术数据。所有手术均通过单一 3-4cm 肋缘下切口和多通道套管进行。收集手术数据,如手术时间、出血、住院时间和并发症的发生情况。我们使用视觉模拟评分(VAS)评估术后疼痛。
自 2018 年 12 月至 2020 年 8 月,同一位外科医生在我科对 6 例不同类型的肾上腺疾病患者进行了连续的 SPORS 手术。所有手术均无需额外套管或转为开放手术。平均手术时间为 91.6±16.3min,出血量<150ml,平均住院时间为 35.8±13.3h,术后疼痛评分 VAS≤3(中位数 0.5)。标本平均大小为 57.8±18mm。根据 Clavien-Dindo 分级,无并发症发生。
即使在初始情况较差的病例中,SPORS 肾上腺切除术也是一种可行且安全的技术,具有良好的美容和围手术期效果。